Ultime notizie per Nuburu (AMEX:BURU) Azioni

Nuburu

Nuburu Inc is a leading innovator in high-power, high-brightness blue laser technology that is focused on bringing breakthrough improvements to multiple markets, including e-mobility, healthcare, and consumer electronics via a broad range of high-value applications that include welding and 3D printing. It is currently shipping blue laser systems for applications such as EV batteries, large screen displays, and cell phone components.

Equities

Market Summary

News

Movers & Shakers

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

General

ADBE

AMPG

BURU

CIEN

DBVT

MAGS

NDSN

Giovedì i future azionari statunitensi sono scesi negli scambi pre-market, dopo aver toccato mercoledì nuovi massimi. I future dei quattro principali indici azionari erano in ribasso. 



I dati sull&#39;inflazione di

Wall Street Pronto ad Aprire al Ribasso un Giorno Dopo il Record di Chiusura del Nasdaq Sopra i 20.000 Punti: Esperto Segnala &#39;Deterioramento Sotto la Superficie&#39; con 117 Azioni S&amp;P 500 a Nuovi Minimi Mensili

Nuburu Inc

Nuburu Inc Class A

Buru Energy Ltd

Raymond James analyst Steve Moss reiterates Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) with a Strong Buy and raises the price target from $74 to $78.

Price Target

Reiteration

Analyst Ratings

INDB

Raymond James Reiterates Strong Buy on Independent Bank, Raises Price Target to $78

RBC Capital analyst Luca Issi reiterates Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) with a Outperform and maintains $30 price target.

RGNX

RBC Capital Reiterates Outperform on Regenxbio, Maintains $30 Price Target

Raymond James analyst David Long reiterates Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) with a Strong Buy and raises the price target from $55 to $58.

Raymond James Reiterates Strong Buy on Citizens Financial Group, Raises Price Target to $58

In the current session, the stock is trading at $49.52, after a 1.56% increase. Over the past month, Cheesecake Factory Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) stock increased by 6.47%, and in the past year, by 53.42%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1737479710_0.png" alt="Past Year Chart" />

<h3>Evaluating Cheesecake Factory P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Cheesecake Factory has a lower P/E than the aggregate P/E of 80.99 of the Hotels, Restaurants &amp; Leisure industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1737479710_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

CAKE

A Look Into Cheesecake Factory Inc's Price Over Earnings

RBC Capital analyst Scott Heleniak reiterates Principal Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) with a Sector Perform and maintains $91 price target.

RBC Capital Reiterates Sector Perform on Principal Finl Gr, Maintains $91 Price Target

Raymond James analyst Josh Beck upgrades Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) from Outperform to Strong Buy and raises the price target from $225 to $300.

Upgrades

Raymond James Upgrades Wix.com to Strong Buy, Raises Price Target to $300

WIIM

LUNR

Intuitive Machines shares are trading higher. The stock may be up on President Trump's comments on space travel and Mars at his inauguration.

Raymond James analyst Josh Beck maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Strong Buy and raises the price target from $150 to $200.

RDDT

Raymond James Maintains Strong Buy on Reddit, Raises Price Target to $200

RBC Capital analyst Luca Issi reiterates Lexeo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEO#NASDAQ">LXEO</a>) with a Outperform and maintains $24 price target.

LXEO

RBC Capital Reiterates Outperform on Lexeo Therapeutics, Maintains $24 Price Target

Bridgewater Associates founder Ray Dalio believes the key to lowering interest rates and balancing out the bond market is reducing the <a href="https://www.benzinga.com/government/regulations/25/01/43059174/buy-long-duration-bonds-says-bank-of-america-strategist">U.S. budget deficit</a>.
What To Know: In an interview from the&nbsp;World Economic Forum on <a href="https://www.cnbc.com/2025/01/21/dalio-says-cutting-budget-deficit-is-crucial-to-stabilize-bond-market.html">CNBC&#8217;s</a> &#8220;Squawk Box&#8221; Tuesday morning, Dalio indicated that there&#8217;s a supply-demand imbalance in the bond market that can be improved if the projected deficit could be lowered to 3%.
&#8220;We have a projected deficit of 7.5% of GDP. That means all those bonds have to be sold,&#8221; Dalio said.
See Also: <a href="https://www.benzinga.com/25/01/43103527/mexican-peso-canadian-dollar-slide-as-trump-threatens-25-tariffs-expert-eyes-price-hikes-on-typical-us-breakfast">Mexican Peso, Canadian Dollar Slide As Trump Threatens 25% Tariffs, Economist Eyes Price Hikes On &#8216;Typical US Breakfast&#8217;</a>
&#8220;When I calculate who are the buyers of the bonds, there will not be enough buyers. And then where it could be worse in this dynamic is those who own bonds also sell the bonds, and when that happens there&#8217;s a tremendous supply &#8230; and then we have problems. We can get into what it looks like, but it&#8217;s happened many times before. So we have to stabilize that, and we can do it.&#8221;
The billionaire investor&nbsp;told CNBC that he calls it &#8220;the 3% solution.&#8221; Most people understand that you can lower the deficit by <a href="https://www.benzinga.com/personal-finance/24/10/41564246/from-10-trillion-to-35-trillion-how-government-spending-has-spiraled-out-of-control">cutting spending</a> and raising taxes, but they often overlook what happens when the economy is strong.
&#8220;If you do it when the economy is good, you will get a lower interest rate. A lower interest rate means less cost of the debt because we have so much debt that the interest costs on the debt is more important than spending and taxes,&#8221; Dalio said.
The federal budget jumped close to 40% in 2024 versus the prior year, pushing the national debt above $36 trillion. Dalio told CNBC that it&#8217;s up to the politicians to work together to figure it out. It&#8217;s certainly achievable if everyone agrees on the 3% target, he added.
&#8220;Our problem isn't the deficit. Our problem is the politics,&#8221; Dalio said. &#8220;The fragmented politics.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43101541/exclusive-powell-co-will-wait-wisdomtree-expert-says-on-why-investors-need-smarter-bond-strategy">EXCLUSIVE: &#8216;Powell &amp; Co. Will Wait&#8217; — WisdomTree Expert On Why Investors Need Smarter Bond Strategy</a></li>
</ul>
Image via Shutterstock

Government

Politics

Billionaire Ray Dalio Says US Budget Deficit Isn't The Problem, It's 'Fragmented' Politics

Raymond James analyst Josh Beck maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Strong Buy and raises the price target from $675 to $725.

Raymond James Maintains Strong Buy on Meta Platforms, Raises Price Target to $725

Raymond James analyst Josh Beck upgrades MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) from Outperform to Strong Buy and maintains the price target from $2250 to $2250.

MELI

Raymond James Upgrades MercadoLibre to Strong Buy, Maintains Price Target to $2250

RBC Capital analyst Karl Shepard reiterates Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) with a Outperform and maintains $20 price target.

HBAN

RBC Capital Reiterates Outperform on Huntington Bancshares, Maintains $20 Price Target

Raymond James analyst Josh Beck maintains GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) with a Strong Buy and raises the price target from $185 to $230.

GDDY

Raymond James Maintains Strong Buy on GoDaddy, Raises Price Target to $230

RBC Capital analyst Luca Issi reiterates Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Outperform and maintains $67 price target.

RBC Capital Reiterates Outperform on Avidity Biosciences, Maintains $67 Price Target

Tuesday, Moderna Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro.
On Friday, Moderna announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/ac43067713/moderna-announces-updates-on-pandemic-influenza-program" rel="noreferrer noopener">pandemic influenza vaccines</a>.
The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR).
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42045488/moderna-remains-confident-despite-political-concerns-over-vaccine-safety-and-hhs-nomination" rel="noreferrer noopener">Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination</a>
The project will support the late-stage development and licensure of pre-pandemic mRNA-based vaccines. The agreement will also expand clinical studies for up to five additional subtypes of pandemic influenza.
In 2023, Moderna commenced a Phase 1/2 study to generate safety and immunogenicity data of an investigational pandemic influenza vaccine (mRNA-1018) in healthy adults 18 years and older.
The study included vaccine candidates against H5 and H7 avian influenza viruses. Based on the preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into Phase 3.
The company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
This $590 million award has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA).
Earlier this month, Moderna announced business updates and progress&nbsp;across its pipeline. Moderna says it enters 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, <a target="_blank" href="https://www.benzinga.com/25/01/42946454/moderna-expects-lower-annual-sales-expands-cost-cutting-initiatives" rel="noreferrer noopener">and latent and other viruses.</a>
Price Action: MRNA stock is up 5.75% at $36.02 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43102213/whats-going-on-with-the-stock-of-foresight-autonomous-today" target="_blank" rel="noreferrer noopener">Foresight Autonomous Inks Commercial Cooperation Pact With Autonomous Drone Manufacturer: Details</a></li>
</ul>
Photo by Lutsenko_Oleksandr on Shutterstock.

Biotech

Large Cap

Health Care

Contracts

Movers

MRNA

Why Is Moderna Stock Trading Higher On Tuesday?

Speaking at the World Economic Forum in Davos 2025, Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) CEO Brian Armstrong placed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) on a higher pedestal than gold as a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114875/coinbase-ceo-brian-armstrong-stands-out-as-candidate-for-donald-trumps-reported-crypto-czar-position-cardano-co-founder-says">store of value for governments</a>.
What Happened: In an <a href="https://www.youtube.com/watch?v=dl9ruFvPlsw">interview</a> with CNBC, Armstrong reflected on spending two days in Washington during Donald Trump's inauguration, describing the event as the "dawn of a new day for crypto." 
He expressed optimism about the new administration&#8217;s potential to establish clear regulations and pass <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43076398/trumps-expected-executive-orders-bitcoins-bullish-surge-and-more-this-week-in-crypto">crypto-friendly legislation</a>, setting the stage for significant investment and innovation. 
He added that crypto is still in "infancy" and it is a very exciting phase.
Armstrong also underscored crypto's early-stage growth, highlighting factors like the rise of Bitcoin ETFs, increased stablecoin payments, and the growing interest of Fortune 500 companies in piloting crypto initiatives. 
He emphasized that Bitcoin, as a global digital asset, could make financial systems faster, cheaper and more efficient, ultimately promoting financial freedom worldwide.
In December 2024, Armstrong openly <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42291096/coinbase-ceo-brian-armstrong-the-us-government-should-never-sell-bitcoin">opposed the U.S. government's decision to sell its Bitcoin</a> holdings, arguing that such assets should be retained as part of a long-term strategy.
Armstrong also hinted at potential partnerships, including integrating <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42741117/coinbase-ceo-brian-armstrong-a-stablecoin-integration-x-would-great-feature">USDC transfers into Elon Musk&#8217;s X platform</a>, signaling a pro-crypto alignment with global financial systems.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43085738/trumps-crypto-silence-inauguration-omission-sparks-questions-after-history-of-mixed-signals">Trump&#8217;s Crypto Silence: Inauguration Omission Sparks Questions After History Of Mixed Signals</a>
What's Next: Armstrong anticipates that the administration&#8217;s first steps will include executive orders directing U.S. government agencies to collaborate on clear crypto regulations. 
Key initiatives could include Attracting capital and enabling startups to thrive in the U.S. and protecting the right to own Bitcoin and use custodial wallets without fear of persecution or de-banking.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43088563/bitcoin-vs-gold-peter-schiff-decodes-trumps-golden-age-reference-in-inaugural-speech">Peter Schiff On Trump&#8217;s Crypto Snub In Inaugural Speech: &#8216;He Invoked Gold, Not Bitcoin&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

Coinbase CEO Brian Armstrong Says Bitcoin's Future Is Bright: 'The Dawn Of A New Day For Crypto'

Raymond James analyst Josh Beck maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Strong Buy and raises the price target from $230 to $260.

AMZN

Raymond James Maintains Strong Buy on Amazon.com, Raises Price Target to $260

RBC Capital analyst Luca Issi reiterates Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Sector Perform and maintains $26 price target.

APLS

RBC Capital Reiterates Sector Perform on Apellis Pharmaceuticals, Maintains $26 Price Target

Shell PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) and Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) are trending across social media platforms on Tuesday. Both oil companies are set to release earnings soon, with Shell expected to report its 2024 fiscal-year fourth-quarter earnings on Jan. 30 and Chevron on Jan. 31.
Analysts expect Shell to report earnings per share of $1.56 and revenue of $49.23 billion. 
Previously, the company <a href="https://www.benzinga.com//node/42870812">lowered its guidance</a> for integrated gas production for the fourth-quarter, now expecting between 880 – 920 kboe/d oil-equivalent barrels per day. This is down from its previous forecast of 900 – 960 boe/d.
Shell also lowered its forecast for LNG production to between 6.8 million and 7.2 million metric tons, down from the previous range of 6.9 million to 7.5 million metric tons.
Analysts estimate earnings per share of $2.19 and revenue of $46.93 billion for Chevron&#8217;s fourth quarter. Chevron had previously indicated that it expects to close asset deals in Canada, Congo, and Alaska throughout the quarter. Additionally, the company said it is working on cost reduction initiatives and aims to achieve $2-3 billion in structural cost savings by the end of 2026, starting from 2024.
Ahead of earnings, Raymond James analyst Justin Jenkins maintained an outperform rating on Chevron and raised the price target from&nbsp;$175&nbsp;to&nbsp;$180.
See Also: <a href="https://www.benzinga.com/news/25/01/43101920/whats-going-on-with-ge-vernova-gev-stock-ahead-of-q4-earnings">What&#8217;s Going On With GE Vernova (GEV) Stock Ahead Of Q4 Earnings?</a>
Price Action: At the time of publication, Chevron stock is trading 0.75% lower at $160.26 and Shell shares are trading 0.26% lower at $66.90, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

SHEL

What's Going On With Shell And Chevron Stock Tuesday?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) stock is on the rise Wednesday alongside strong trading of the blue laser company&rsquo;s shares.



As of this writing, roughly 35 million shares of BURU stock have changed hands. That comes in above the company&rsquo;s daily average trading volume. It&rsquo;s also worth noting that the company&rsquo;s <a href="https://finance.yahoo.com/quote/BURU/key-statistics/">float is about 381,190 units</a>.



While there&rsquo;s no news today behind this movement, it could be tied to an announcement from a couple of days ago. That includes the company obtaining $500,000 in funding through an unsecured, subordinated convertible note.



<h2>Details of BURU Stock Note</h2>



This note has a 5% OID, 15% interest and a six-month maturity date. The face amount of the loan is $525,000. The note is also convertible to BURU stock for a 25% discount to a 10% premium to the shares&rsquo; price on execution or the lowest daily VWAP during the 10 days prior to conversion.



Esousa is behind the latest convertible note and also holds senior convertible notes for Nuburu. It agreed to extinguish $500,000 of these notes in exchange for the new convertible note.



It&rsquo;s also worth noting that Esousa is a 9.9% shareholder in BURU stock. This comes from the 729,299 shares owned by the company.



BURU stock is up 47% as of Wednesday morning.



There are more stock market stories traders need to know about below!



We have all of the hottest stock market news ready to go on Wednesday! That includes all of the latest news for Clover Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/clov-stock-quote/">CLOV</a>), Brinker&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) and Victoria&rsquo;s Secret&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/vsco-stock-quote/">VSCO</a>) stock. You can catch up on these matters at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/08/clov-stock-alert-what-to-know-about-clover-healths-big-insider-buy/">CLOV Stock Alert: What to Know About Clover Health&rsquo;s Big Insider Buy</a></li>



<li><a href="https://investorplace.com/2024/08/eat-stock-alert-why-shares-of-brinker-are-plunging-today/">EAT Stock Alert: Why Shares of Brinker Are Plunging Today</a></li>



<li><a href="https://investorplace.com/2024/08/victorias-secret-news-whats-going-on-with-vsco-stock-today/">Victoria&rsquo;s Secret News: What&rsquo;s Going On With VSCO Stock Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-nuburu-buru-stock-up-47-today/">Why Is Nuburu (BURU) Stock Up 47% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Nuburu (BURU) Stock Up 47% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) just reported results for the second quarter of 2024.<ul><li>Nuburu reported earnings per share of -$7.60.</li><li>The company reported revenue of $49,278.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/buru-stock-earnings-nuburu-for-q2-of-2024/">BURU Stock Earnings: Nuburu Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BURU Stock Earnings: Nuburu Reported Results for Q2 2024

Nuburu jumps 60%, gets $65M financing from Liqueous LP fund

ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management

NUBURU receives NYSE non-compliance notice

Nuburu (BURU) received from NYSE Regulation a Warning Letter describing violations by the company of Sections 301 and 713 of the Company Guide. Sec...

Nuburu receives and resolves NYSE non-compliance notification

Option delistings effective December 23rd include Pieris Pharmaceuticals (PVLA), Nanostring Technologies, Inc. (NSTGQ), NaaS Technology (NAAS), ROU...

Twelve option delistings on December 23rd

Nuburu ( ($BURU) ) has provided an update. On January 13, 2025, Nuburu, Inc. reached an agreement with S.F.E. Equity Investments SARL to address ou...

Nuburu Announces Leadership Changes and New Agreement

ATRA

CDTX

GRTX

NAAS

PVLA

RCMT

Leaders in The News: FuelCell Energy, WeightWatchers, NUBURU, New World Solutions

Press Releases

NUBURU Announces Transition to New Equity Line of Credit

New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST

Penny Stocks

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST

NUBURU Announces Cancellation of Special Proxy Statement

Bloomberg's "New to The Street" Segment by PetVivo Inc. (OTCQB: PETV) Stocks to Watch This Week inside….

Financing

Liqueous LP Finalizes $100 Million Equity Line of Credit With Crown Electrokinetics Corp, Building on Strategic Recapitalization Efforts and separately provides NUBURU Financing Update

Comments

Nuburu

Notizie

Ultime notizie per Nuburu (AMEX:BURU) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO